头颈癌患者医疗协助死亡的选择与死亡分析
最常见原发部位为口腔(109人,30.6%),最常见原因为非疼痛症状控制不足(79.21%),其次为疼痛控制不足或担忧(75%)。MAiD使用逐年线性增加,且患者多居住于富裕社区和大城市中心。
要点
- 头颈癌患者MAiD使用自合法化以来持续增加,预计继续上升。
- 男性占73.03%,与全国头颈癌发病率一致。
- 最常见MAiD原因为非疼痛症状控制不足(79.21%)。
核心结论
- 头颈癌患者MAiD使用自合法化以来稳步增加,预计继续增加。
- MAiD是接受非治愈性治疗的头颈癌患者日益增加的选择。
研究设计与样本
- 回顾性横断面分析,数据来自加拿大安大略省首席验尸官办公室,期间为2016年6月17日至2022年12月31日。
主要发现
- 平均年龄72.4岁(SD 12.22),男性260人(73.03%)。
- 最常见原发肿瘤部位为口腔,109人(30.6%)。
- 最常见原因为非疼痛症状控制不足(79.21%),其次为疼痛控制不足或担忧(75%)。
- 最常见地点为患者私人住所(55.62%)。
- 患者更可能居住在富裕社区和大城市中心。
临床怎么用
- 临床应关注头颈癌患者非疼痛症状控制及疼痛管理,可能影响MAiD需求。
- 了解MAiD使用趋势有助于识别当前护理系统的不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care. METHODS: This is a retrospective cross-sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada. RESULTS: Three hundred and fifty-six persons received MAiD. The average age was 72.4 years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%). The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%). The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoods and in large urban centers. Future prediction of MAiD uptake shows a linear year-by-year increase. CONCLUSION: The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent.
引用
- Curry T, Wener E, Odell M, et al. Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario. Laryngoscope. 2026. PMID: 41636338. doi:10.1002/lary.70410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。